Bonell Patiño-Escobar

7PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 22, 2026
Synergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody-Drug Conjugates.

Anil P Bidkar, Scott Bidlingmaier, Anju Wadhwa

|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.

Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar

|Apr 23, 2025
Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia.

Juwita Werner, Alex G Lee, Chujing Zhang

|Dec 18, 2023
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma.

Anju Wadhwa, Sinan Wang, Bonell Patiño-Escobar

|Oct 31, 2023
Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target.

Kamal Mandal, Gianina Wicaksono, Clinton Yu

|Jul 15, 2022
The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance.

Ian D Ferguson, Bonell Patiño-Escobar, Sami T Tuomivaara

Pageof 2

Frequent Collaborators

7 joint publications

Arun Wiita

3 joint publications

Adila Izgutdina

3 joint publications

Elliot Stieglitz

2 joint publications

Scott Bidlingmaier